Quarterly Cardiology CME Series
Washington University and Barnes-Jewish Heart & Vascular Center is one of the leading innovative clinical, teaching and research programs in the nation. This CME series we will provide the tools needed for physicians to understand and diagnose heart disease, in addition to an evening of heart healthy fine dining. The lessons learned at our CME events will grant physicians access to the latest ground-breaking research and procedures in the St. Louis area.
Washington University and Barnes-Jewish Heart & Vascular Center in West County
1020 North Mason Road, 2nd Floor
Medical Office Building #3
Creve Coeur, MO 63141
||Reception and Registration (Dinner catered by Morrisons Food Service)
||Physician Talk and Q&A
||Tour of facility (Optional)
February 20, 2013
Speaker: Dr. Anita Bhandiwad
Topic: Hormone Replacement and Heart Disease
Cardiovascular disease in women tends to manifest later in life compared to men. Early studies suggested protective benefits of estrogen. Menopausal changes may contribute to changes in cardiovascular risk. Over many decades, women have been given hormone replacement therapy, perhaps even with the intent of reducing cardiovascular risk. More recent studies, however, have challenged this approach. This lecture aims to review the historical and current perspective on cardiovascular issues in the post-menopausal patient.
1. Recognize cardiovascular changes in menopause
2. Evaluate data on cardiovascular effects of estrogen
3. Be aware of the role in primary and secondary prevention of coronary artery disease
April 11, 2013
Speaker: Dr. Phillip Cuculich
Topic: Drugs, Devices, Ablations…What to Know About Atrial Fibrillation Treatments
Atrial fibrillation (AF) is the single most common heart rhythm disorder. AF dramatically increases risks for stroke, the most dreaded complication of the disease. For some patients, AF can cause significant symptoms of palpitations, shortness of breath, exercise intolerance or fatigue. With a wave of innovative medications, devices, and procedures newly available, the question remains for the treating health care providers: “When should I offer these treatments to my patients with atrial fibrillation?” This lecture introduces the latest advances in AF treatment and addresses the appropriateness for each intervention in a patient-by-patient manner.
1. To recognize the three main pillars of atrial fibrillation management:
a. anticoagulation to reduce stroke risk
b. rate control to help symptoms
c. rhythm control to maintain a normal sinus rhythm
2. To provide updates on the indications, success rates, risks, and recovery of an atrial fibrillation ablation procedure
3. To learn about the future of advanced therapies for atrial fibrillation to further reduce stroke risks and minimize symptoms.
The purpose of this series is to increase competence, performance and skill, and improve patient outcomes regarding current disease states, testing and treatment options. The scope of this program will include cardiology.
Washington University designates this live educational activity for a maximum of _1_ AMA PRA Category 1 Credits TM (for each instance) per session. Physicians should only claim credit commensurate with the extent of their participation in the activity.
It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.
All faculty participating in this activity are expected to disclose to the audience any financial interest or other relationship he/she has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. All physicians’ disclosures were reported and are indicated with their presentations. Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are the views and experiences of the presenters. The presenters’ views do not represent the policy or position of Washington University School of Medicine. Washington University School of Medicine, Continuing Medical Education is the sponsor for CME credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you have any questions about this CME event, please contact Renee Douglas at 314-454-7209 or firstname.lastname@example.org.
September 26, 2012
Speaker: Dr. Susan Joseph
Topic: Diagnosis and Management of Heart Failure Made Easy
Heart failure is an inability of the heart to provide sufficient pump action to distribute blood to meet the needs of the body. Symptoms include shortness of breath, leg swelling, and exercise intolerance. Heart failure affects approximately 5 million Americans with 500,000 new cases diagnosed each year in the United States. It is the leading cause of hospitalization in individuals older than 65 years, and affects as many as 6-10% of adults over 65. This lecture aims to discuss how heart failure is diagnosed and managed, as well as recent advances in the field.
1. Discuss the clinical manifestations and diagnosis of heart failure
2. Discuss up-to-date medical management of heart failure
3. Discuss indications for devices in heart failure (ICDs, CRTs, and Left ventricular assist devices.)
November 8, 2012
Speaker: Dr. Craig Reiss
Topic: Treatment of Aortic Valve Disease
Aortic stenosis is a very common valvular disorder with fatal consequences if not diagnosed and treated appropriately. The timing and intervention on valvular aortic disease can be challenging to the clinician. This lecture will review the symptoms and treatment of patients with aortic stenosis focusing on the elderly patent and address timing of aortic stenosis in the appropriate asymptomatic patient, along with exploring the impact of new treatment modalities.
1. Identify issues around timing of aortic valve surgery in patients with aortic disease
2. Be aware of newer technology and treatment for aortic disease
3. Be aware of symptoms of aortic disease in the elderly